AYTU BIOPHARMA CEO Joshua Disbrow's 2023 pay rises 20% to $708K
AYTU BIOPHARMA reports 2023 executive compensation
By ExecPay News
Published: May 10, 2024
AYTU BIOPHARMA reported fiscal year 2023 executive compensation information on May 10, 2024.
In 2023, three executives at AYTU BIOPHARMA received on average a compensation package of $590K, a 23% increase compared to previous year.
Average pay of disclosed executives at AYTU BIOPHARMA
Joshua R. Disbrow, Chief Executive Officer, received $708K in total, which increased by 20% compared to 2022. 83% of Disbrow's compensation, or $590K, was in salary. Disbrow also received $118K in bonus.
Greg Pyszczymuka, Chief Commercial Officer since January, received a compensation package of $540K. 69% of the compensation package, or $375K, was in salary.
Mark K. Oki, Chief Financial Officer, earned $523K in 2023, a 42% increase compared to previous year.
AYTU BIOPHARMA's fiscal year ends on June 30.
Related executives
You may also like
Source: SEC filing on May 10, 2024.